skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 15,877  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
Material Type:
Article
Add to My Research

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial

Lancet neurology, 2020-02, Vol.19 (2), p.115-122 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(19)30395-3 ;PMID: 31831388

Full text available

2
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Material Type:
Article
Add to My Research

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

The New England journal of medicine, 2018-12, Vol.379 (24), p.2297-2306 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1805374 ;PMID: 30145927

Full text available

3
Gastric cancer
Material Type:
Article
Add to My Research

Gastric cancer

The Lancet (British edition), 2020-08, Vol.396 (10251), p.635-648 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31288-5

Full text available

4
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Material Type:
Article
Add to My Research

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

The Lancet, 2020-02, Vol.395 (10223), p.e30-e31 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30304-4 ;PMID: 32032529

Digital Resources/Online E-Resources

5
Progress towards therapies for disease modification in Parkinson's disease
Material Type:
Article
Add to My Research

Progress towards therapies for disease modification in Parkinson's disease

Lancet neurology, 2021-07, Vol.20 (7), p.559-572 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00061-2

Full text available

6
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial

JAMA, 2020-08, Vol.324 (5), p.460 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.10044

Digital Resources/Online E-Resources

7
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
Material Type:
Article
Add to My Research

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

Clinical infectious diseases, 2018-01, Vol.66 (2), p.163-171 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;Copyright Oxford University Press, UK Jan 15, 2018 ;The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2017 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/cix783 ;PMID: 29020404

Full text available

8
Determinants of ICS Therapy Adherence in Patients With Asthma
Material Type:
Article
Add to My Research

Determinants of ICS Therapy Adherence in Patients With Asthma

The American journal of managed care, 2021-02, Vol.27 (2), p.1 [Peer Reviewed Journal]

Copyright Intellisphere, LLC Feb 2021 ;ISSN: 1088-0224 ;EISSN: 1936-2692

Full text available

9
Anxiety disorders
Material Type:
Article
Add to My Research

Anxiety disorders

The Lancet (British edition), 2021-03, Vol.397 (10277), p.914-927 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00359-7 ;PMID: 33581801

Full text available

10
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Material Type:
Article
Add to My Research

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

The Lancet, 2020-06, Vol.395 (10241), p.1919-1926 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31173-9 ;PMID: 32473682

Digital Resources/Online E-Resources

11
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Material Type:
Article
Add to My Research

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

New England Journal of Medicine, 2022-04, Vol.386 (15), p.1397-1408 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118542 ;PMID: 35172054

Digital Resources/Online E-Resources

12
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Material Type:
Article
Add to My Research

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetes care, 2018-12, Vol.41 (12), p.2669-2701 [Peer Reviewed Journal]

2018 American Diabetes Association and European Association for the Study of Diabetes. ;Copyright American Diabetes Association Dec 1, 2018 ;2018 American Diabetes Association and European Association for the Study of Diabetes. 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci18-0033 ;PMID: 30291106

Full text available

13
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Material Type:
Article
Add to My Research

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Leukemia, 2019-01, Vol.33 (1), p.159-170 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-018-0196-8 ;PMID: 29967379

Full text available

14
Potential effects of curcumin in the treatment of COVID‐19 infection
Material Type:
Article
Add to My Research

Potential effects of curcumin in the treatment of COVID‐19 infection

Phytotherapy Research, 2020-11 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/ptr.6738

Digital Resources/Online E-Resources

15
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
Material Type:
Article
Add to My Research

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

European journal of cancer (1990), 2019-07, Vol.116, p.116-136 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0959-8049 ;EISSN: 1879-0852 ;DOI: 10.1016/j.ejca.2019.04.031

Digital Resources/Online E-Resources

16
Pathophysiology, diagnosis, and management of endometriosis
Material Type:
Article
Add to My Research

Pathophysiology, diagnosis, and management of endometriosis

BMJ (Online), 2022-11, Vol.379, p.e070750 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2022BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-070750 ;PMID: 36375827

Full text available

17
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2019-10, Vol.394 (10208), p.1540-1550 [Peer Reviewed Journal]

2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32135-X

Full text available

18
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Material Type:
Article
Add to My Research

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

JAMA, 2020-04, Vol.323 (16), p.1574 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.5394

Digital Resources/Online E-Resources

19
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
Material Type:
Article
Add to My Research

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

The Lancet (British edition), 2020-08, Vol.396 (10248), p.381-389 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31356-8 ;PMID: 32679111

Full text available

20
AB0207 ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTING
Material Type:
Article
Add to My Research

AB0207 ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTING

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1128-1130 [Peer Reviewed Journal]

2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-eular.955

Full text available

Results 1 - 20 of 15,877  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (12,535)

Refine My Results

Creation Date 

From To
  1. Before 1975  (19)
  2. 1975 To 1987  (54)
  3. 1988 To 1999  (263)
  4. 2000 To 2012  (5,891)
  5. After 2012  (9,669)
  6. More options open sub menu

Subject 

  1. Medical Treatment  (15,149)
  2. Science & Technology  (9,501)
  3. Life Sciences & Biomedicine  (8,216)
  4. Humans  (7,184)
  5. Female  (3,844)
  6. Male  (3,735)
  7. Middle Aged  (2,748)
  8. Adult  (2,534)
  9. Surgery  (2,283)
  10. Aged  (2,136)
  11. Medicine  (2,083)
  12. Hospitals  (2,044)
  13. Care And Treatment  (1,880)
  14. Health Services  (1,842)
  15. Cancer  (1,738)
  16. Clinical Trials  (1,685)
  17. Mortality  (1,621)
  18. Risk Factors  (1,490)
  19. Medical Research  (1,455)
  20. More options open sub menu

Language 

  1. English  (15,748)
  2. Japanese  (924)
  3. French  (78)
  4. Portuguese  (41)
  5. Spanish  (25)
  6. German  (24)
  7. Chinese  (20)
  8. Norwegian  (17)
  9. Turkish  (12)
  10. Russian  (8)
  11. Polish  (6)
  12. Danish  (6)
  13. Italian  (4)
  14. Slovenian  (4)
  15. Swedish  (4)
  16. Arabic  (2)
  17. Malay  (2)
  18. Afrikaans  (2)
  19. Slovak  (1)
  20. More options open sub menu

Searching Remote Databases, Please Wait